Skip to main content
Fig. 2 | Antimicrobial Resistance & Infection Control

Fig. 2

From: Impact of the COVID-19 pandemic on extended-spectrum β-lactamase producing Escherichia coli in urinary tract and blood stream infections: results from a nationwide surveillance network, Finland, 2018 to 2022

Fig. 2

The annual proportion of extended-spectrum β-lactamase-producing Escherichia coli in urine E. coli isolates among (A) males and (B) females and in blood E. coli isolates among (C) males and (D) females, Finland, 2019–2022. AAD: average annual decrease; CI: compatibility interval; ESBL+: extended-spectrum β-lactamase-producing Escherichia coli

Back to article page

Antimicrobial Resistance & Infection Control

ISSN: 2047-2994

Contact us